Britt Erickson is an Oncology physician affiliated with University of Minnesota. OpenAlex indexes 277 publications with 2,535 citations (h-index 26); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Sponsor: National Cancer Institute (NCI)
- Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer
Sponsor: National Cancer Institute (NCI)
- Salpingectomy at Cesarean Delivery for Ovarian Cancer Reduction (SCORE)
Sponsor: University of Alabama at Birmingham
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AbbVieProgram year20254 paymentsResearch$813,882openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20252 payments
- AbbVieProgram year20241 paymentResearch$64,872openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
NIH funding
1 NIH research award on record, funded 2023–2026 per NIH RePORTER. The latest:
- Increasing access to cancer trials in Minnesota (InACT-MN)
University of Minnesota
FY2026$182,836R50CA278811 - Increasing access to cancer trials in Minnesota (InACT-MN)
University of Minnesota
FY2025$182,836R50CA278811 - Increasing access to cancer trials in Minnesota (InACT-MN)
University of Minnesota
FY2024$182,836R50CA278811
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Jay Cohn, MD
University of Minnesota
Douglas Yee, MD
University of Minnesota
David Benditt, MD
University of Minnesota
Stuart Grossman, MD
University of Minnesota
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”